Avalyn Pharma Inc.
AVLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540171
No open-market purchases or sales by Avalyn Pharma Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $1.46B in total; Soros Fund Management is the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding Avalyn Pharma Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 0 | 93 | +93 |
| Shares | 0 | 44.3M | +44.3M |
| Value | $0 | $1.46B | +$1.46B |
New holders (93)
Institutions that held Avalyn Pharma Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (0)
Institutions that held Avalyn Pharma Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
None.